Kegg medicus dgroup en
| DG02000 | |
| DG number | DG02000 |
| Classification | DGroup |
| Name | HCV NS5B polymerase inhibitor |
| Stem | -buvir TYPE Target, Class |
| Structural formula |  |
| Member | D00423 Ribavirin (JP18/USP/INN) D10366 Sofosbuvir (JAN/USAN/INN) DG01886 Dasabuvir D10553 Dasabuvir (USAN/INN) D10581 Dasabuvir sodium hydrate DG01824 Beclabuvir D10610 Beclabuvir (USAN/INN) D10611 Beclabuvir hydrochloride (JAN/USAN) DG01828 Deleobuvir D10554 Deleobuvir (USAN/INN) D10622 Deleobuvir sodium (JAN/USAN) DG03210 Bemnifosbuvir D12255 Bemnifosbuvir (USAN) D12260 Bemnifosbuvir sulfate (USAN) D08951 Nesbuvir (USAN) D09616 Filibuvir (USAN/INN) D09971 Tegobuvir (USAN/INN) D10165 Setrobuvir (USAN) D10425 Lomibuvir (USAN/INN) D10996 Uprifosbuvir (USAN/INN) D10477 Mericitabine (USAN/INN) |
| Upper group | Antiviral DG03198 Anti-HCV agent |
| Remark | - |
| Comment | - |